Next-Generation Blood Test Improves Detection of Aggressive Prostate Cancer
A study of more than 12,600 men found the Stockholm3 blood test detected significantly more aggressive prostate cancers than the standard PSA test, without increasing unnecessary follow-up testing.
Health News is provided as a service to Carrington Drug site users by HealthDay. Carrington Drug nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.